Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:48:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:29:06.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T00:24:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:55:03.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:50:51.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the study's objectives, inclusion and exclusion criteria for participants, and details about the investigational drugs. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    10%
    Check dated 2025-04-16T14:49:46.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.